CLNN Overview
Upcoming Projects (CLNN)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (CLNN)
-
A Second View: Investigating the recent data from the Phase 2 VISIONARY-MS clinical trial of CNM-Au8 in patients with multiple sclerosis
Ticker: CLNN
Executed On: May 28, 2024 at 04:00 PM EDT -
Investigating the recent data from the Phase 2 VISIONARY-MS clinical trial of CNM-Au8 in patients with multiple sclerosis
Ticker: CLNN
Executed On: May 14, 2024 at 04:00 PM EDT -
A second look at the current standard of care and the potential of Clene Nanomedicines' CNM-Au8 long-term survival improvement in the HEALEY ALS Platform Trial for ALS
Ticker: CLNN
Executed On: Dec 07, 2023 at 06:15 PM EST -
A look at the current standard of care and the potential of Clene Nanomedicines' CNM-Au8 long-term survival improvement in the HEALEY ALS Platform Trial for ALS
Ticker: CLNN
Executed On: Oct 05, 2023 at 04:00 PM EDT -
Reviewing the clinical landscape for MS with a look at Clene Nano-medicine and their potential gold nanocrystal suspension therapy, CNM-Au8
Ticker: CLNN
Executed On: Sep 21, 2022 at 04:15 PM EDT -
A Second View: Discussing the recent FDA approval for Radicava ORS (edaravone) - orally administered version of Radicava on the treatment landscape of ALS
Tickers: MTPA, CLNN
Executed On: Jul 22, 2022 at 02:00 PM EDT
Upcoming & Overdue Catalysts (CLNN)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (CLNN)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
